Inventor · disambiguated record
Michael Kessler
Also filed as: KESSLER MICHAEL · KESSLER MICHAEL D
1 granted patent·4 pending applications·0 citations·filing 2022–2024
13Inventor score
Technology areasC12Q
Files withREGENERON PHARMA5
Top patents by PatentIndex Score
5 records- 0174US2025170226A1Methods Of Treating Skin Cancer With Histidine Ammonia-Lyase (HAL) AgonistsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0266US12186378B2Methods of treating skin cancer with histidine ammonia-lyase (HAL) agonistsREGENERON PHARMA·Filed 2022·Granted Jan 7, 2025·0 cites·10 claims
- 0359US2023113866A1Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential (CHIP) With Lymphocyte Antigen 75 (LY75), Cluster Of Differentiation 164 (CD164), Or Poly(ADP-Ribose) Polymerase 1 (PARP1) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0456US2023340598A1Association Of T Cell Leukemia/Lymphoma Protein 1A (TCL1A) With Clonal Hematopoiesis Of Indeterminate Potential (CHIP)REGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0554US2023383351A1Rare Variants In Hematopoietic Stem Cells (HSC) And Hematopoietic Progenitor Cells (HPC) Associated With Somatic Alterations Of The BloodREGENERON PHARMA·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Kessler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →